Differences in intestinal microbiome are associated with the mortality of COVID-19 patients in intensive care units.
作者信息
Wu Dong, Zhou Kaichen, Xiao Meng, Liu Zhihua, Zhang Shuyang
机构信息
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
National Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
出版信息
Sci China Life Sci. 2022 May;65(5):1040-1042. doi: 10.1007/s11427-021-2072-4. Epub 2022 Feb 11.
Abstract
摘要
相似文献
1
Differences in intestinal microbiome are associated with the mortality of COVID-19 patients in intensive care units.肠道微生物群的差异与重症监护病房中新冠病毒肺炎患者的死亡率相关。
Sci China Life Sci. 2022 May;65(5):1040-1042. doi: 10.1007/s11427-021-2072-4. Epub 2022 Feb 11.
2
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.促炎肠道微生物组特征 SARS-CoV-2 感染患者，抗炎细菌网络连通性降低与严重 COVID-19 相关。
Front Cell Infect Microbiol. 2021 Nov 17;11:747816. doi: 10.3389/fcimb.2021.747816. eCollection 2021.
3
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
4
COVID-19 Mortality Differences: Patient-related Data and Intensive Care Unit Load Are Prerequisites.新冠病毒疾病（COVID-19）死亡率差异：患者相关数据和重症监护病房负荷是前提条件。
Ann Am Thorac Soc. 2022 Sep;19(9):1622-1623. doi: 10.1513/AnnalsATS.202203-230LE.
5
Impact of COVID-19 on the Intestinal Microbiome.新冠疫情对肠道微生物组的影响。
Curr Nutr Rep. 2021 Dec;10(4):300-306. doi: 10.1007/s13668-021-00375-z. Epub 2021 Nov 23.
6
Long-term mortality of elderly patients after intensive care unit admission for COVID-19.COVID-19患者入住重症监护病房后老年患者的长期死亡率。
Intensive Care Med. 2021 Jun;47(6):710-712. doi: 10.1007/s00134-021-06399-x. Epub 2021 Apr 12.
7
Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?MAFLD患者发生重症COVID-19的风险增加是否与肠-肝轴紊乱有关？
J Hepatol. 2021 Feb;74(2):487-488. doi: 10.1016/j.jhep.2020.05.051. Epub 2020 Jun 20.
8
Detection of SARS-CoV-2 genome on inanimate surfaces in COVID-19 intensive care units and emergency care cohort.在 COVID-19 重症监护病房和急症护理队列中对无生命表面上的 SARS-CoV-2 基因组进行检测。
Braz J Microbiol. 2022 Mar;53(1):213-220. doi: 10.1007/s42770-021-00674-1. Epub 2022 Jan 6.
9
Six-month follow-up of gut microbiota richness in patients with COVID-19.新型冠状病毒肺炎患者肠道微生物群丰富度的六个月随访
Gut. 2022 Jan;71(1):222-225. doi: 10.1136/gutjnl-2021-324090. Epub 2021 Apr 8.
10
One-year mortality after ICU admission due to COVID-19 infection.因新冠病毒感染入住重症监护病房后的一年死亡率。
Intensive Care Med. 2022 Mar;48(3):366-368. doi: 10.1007/s00134-021-06611-y. Epub 2022 Jan 18.
引用本文的文献
1
Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database.肺炎与肠道感染之间的双向关联：MIMIC-IV数据库分析
Intern Emerg Med. 2025 Jan;20(1):225-234. doi: 10.1007/s11739-024-03631-6. Epub 2024 May 8.
2
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.肠道微生物群与 COVID-19 进展的关系：对免疫发病机制和治疗的新认识。
Front Immunol. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336. eCollection 2023.
本文引用的文献
1
Viable SARS-CoV-2 in various specimens from COVID-19 patients.不同 COVID-19 患者样本中存活的 SARS-CoV-2。
Clin Microbiol Infect. 2020 Nov;26(11):1520-1524. doi: 10.1016/j.cmi.2020.07.020. Epub 2020 Jul 23.
2
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况：系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.
3
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.2019 年冠状病毒病或 H1N1 流感患者肠道微生物组的改变。
Clin Infect Dis. 2020 Dec 17;71(10):2669-2678. doi: 10.1093/cid/ciaa709.
4
PICRUSt2 for prediction of metagenome functions.用于宏基因组功能预测的PICRUSt2
Nat Biotechnol. 2020 Jun;38(6):685-688. doi: 10.1038/s41587-020-0548-6.
5
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.腹泻型肠易激综合征患者的腔内和黏膜相关肠道微生物群。
Gut Pathog. 2010 Dec 9;2(1):19. doi: 10.1186/1757-4749-2-19.
6
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces.人类胃肠道中与黏膜相关的细菌沿结肠均匀分布，且与从粪便中获得的菌群不同。
Appl Environ Microbiol. 2002 Jul;68(7):3401-7. doi: 10.1128/AEM.68.7.3401-3407.2002.
Zotero 插件